Palliative care ‐ new approaches to the problem of suffering

2000; Wiley; Volume: 30; Issue: 3 Linguagem: Inglês

10.1111/j.1445-5994.2000.tb00841.x

ISSN

0004-8291

Autores

David W. Kissane, Odette Spruyt, Sanchia Aranda,

Tópico(s)

Family and Patient Care in Intensive Care Units

Resumo

Australian and New Zealand Journal of MedicineVolume 30, Issue 3 p. 377-384 Full Access Palliative care - new approaches to the problem of suffering D. W. Kissane, Corresponding Author D. W. Kissane Professor/Director of Palliative Medicine, Department of Medicine (St Vincent's), University of Melbourne, Melbourne, Vic.Reprint requests to: Professor D. W. Kissane, 104 Studley Park Road, Kew, Vic 3101.Search for more papers by this authorO. Spruyt, O. Spruyt Head of Palliative Care, Peter MacCallum Cancer Institute, Melbourne, Vic.Search for more papers by this authorS. Aranda, S. Aranda Associate Professor of Palliative Care and Deputy Head, Postgraduate School of Nursing, University of Melbourne, Melbourne, Vic.Search for more papers by this author D. W. Kissane, Corresponding Author D. W. Kissane Professor/Director of Palliative Medicine, Department of Medicine (St Vincent's), University of Melbourne, Melbourne, Vic.Reprint requests to: Professor D. W. Kissane, 104 Studley Park Road, Kew, Vic 3101.Search for more papers by this authorO. Spruyt, O. Spruyt Head of Palliative Care, Peter MacCallum Cancer Institute, Melbourne, Vic.Search for more papers by this authorS. Aranda, S. Aranda Associate Professor of Palliative Care and Deputy Head, Postgraduate School of Nursing, University of Melbourne, Melbourne, Vic.Search for more papers by this author First published: 25 March 2008 https://doi.org/10.1111/j.1445-5994.2000.tb00841.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Seale C. Heroic death. Sociol 1995; 29: 597–613. 2 Field D. Awareness and modern dying. Mortality 1996; 1: 255–66. 3 McNamara B, Waddell C, Colvin M. The institutionalisation of the good death. Soc Sci Med 1994; 39: 1501–8. 4 Inturrisi CE. Opioid pharmacology: tolerance, receptor modulation, and new analgesics. In: R Payne, RB Patt, CS Hill (Eds.). Assessment and treatment of cancer pain. Progress in pain research and management. Vol 12. Seattle : IASP Press, 1998; 275–88. 5 de Stoutz ND, Bruera E et al. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995; 10: 378–84. 6 Fallon M. Opioid rotation: does it have a role Palliat Med 1997; 11: 177–8. 7 Ahmedzai S. New approaches to pain control in patients with cancer. Eur J Cancer 1997; 33 (Suppl. 6): 8–14. 8 Portenoy RK, Southam MA, Gupta SK et al. Transdermal fentanyl for cancer pain: repeated dose pharmacokinetics. Anesthesiol 1993; 78: 36–43. 9 Raffa RB, Friderichs E, Reimann W et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharm Exper Therapeut 1992; 260: 275–85. 10 Lee CR, McTavish D, Sorkin EM et al. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46: 313–40. 11 Bruera E, Belzile M, Pituskin E et al. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol 1998; 16: 3222–9. 12 Babul M, Darke AC. Putative role of hydromorphone metabolites in myoclonus. Pain 1992; 51: 260–1. 13 Vallner J, Stewart J, Kotzan J et al. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharm 1981; 21: 152–6. 14 Twycross RG. A comparison of diamorphine with cocaine and methadone. Br J Clin Pharm 1977; 4: 691–3. 15 Mercadante S, Casuccio A, Calderone L. Rapid switching from morphine to methadone in cancer patients with poorly responsive pain to morphine. J Clin Oncol 1999; 17: 3307–12. 16 Morley JS, Makin MK. An update on the clinical use of methadone for cancer pain. Pain 1997; 73: 114. 17 Makin MK, Ellershaw JE. Substitution of anodier opioid for morphine. Mediadone can be used to manage neuropathic pain related to cancer. Br Med J 1998; 317: 81. 18 Ripamonti C, Zecca E, Bruera E et al. An update on the clinical use of methadone for cancer pain. Pain 1997; 70: 109–15. 19 Finlay I. Ketamine and its role in cancer pain. Pain Rev 1999; 6: 303–13. 20 Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine Pain 1998; 74: 337–9. 21 Price DD, Mao J, Frenk H et al. The N-methyl-D-aspartate antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59: 165–74. 22 McQuay HM, Carrol D, Jadad AR et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind, randomised controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127–34. 23 Field MJ, Oles RJ et al. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective anti-hyperalgesic agents. Br J Pharmacol 1997; 121: 1513–22. 24 Mellecik LB, Mellick GA, Mellicy LB. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage 1995; 10: 265–6. 25 Wetzel CH, Connelly JF. Use of gabapentin in pain management. Ann Pharmacother 1997; 3: 1082–3. 26 Rosenberg JM, Harrell C, Ristic H et al. The effect of gabapentin on neuropathic pain. Clin J Pain 1997; 13: 251–5. 27 Rowbotham MC, Reisner-KeUer LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024–8. 28 Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991; 45: 145–8. 29 Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide and meziletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38: 333–8. 30 Eisenbach JC, Du Pen SL, Dubois M et al. Epidural clonidine analgesia for intractable cancer pain. Pain 1995; 61: 391–9. 31 Berenson JR, Lichenstein A, Porter L et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced myeloma. N Engl J Med 1996; 334: 488–93. 32 Hortobagyi GN, Theriault RL, Porter L Efficacy of pamidronate in reducing skeletal complication in patients with breast cancer and lytic bone metastases N Engl J Med 1996; 335: 1785–91. 33 Hortobagyi GN, Theriault RL, Lipton A et al. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 1998; 16: 2038–44. 34 Cassell EJ. The nature of suffering and the goals of medicine. N Engl J Med 1982; 306: 639–45. 35 Cherny NI, Coyle N, Foley KM. Suffering in the advanced cancer patient: a definition and taxonomy. J Pall Care 1994; 10: 57–70. 36 Cherny NI, Coyle N, Foley KM. The treatment of suffering when patients request death. J Pall Care 1994; 10: 71–9. 37 Chochinov HM, Wilson KG, Enns M et al. Desire for death in the terminally ill. Am J Psychiat 1995; 152: 1185–91. 38 Bruera E, Neumann CM. The uses of psychotropics in symptom management in advanced cancer. Psycho-Oncology 1998; 7: 346–58. 39 S Strack (Ed.). Death and the quest for meaning. Northvale , NJ : Aronson, 1997. 40 MacLeod R, Carter H. Health professionals' perception of hope: understanding its significance in the care of people who are dying. Mortality 1999; 4: 309–17. 41 Glick SM. Unlimited human autonomy – a cultural bias N Engl J Med 1997; 336: 954–7. 42 Dufault K, Martocchio BC. Hope: its spheres and dimensions. Nurs Clin North Am 1985; 20: 379–91. 43 Fava GA, Freyberger HJ, Bech P et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1–8. 44 American Psychiatric Association. Diagnostic and statistical manual (DSM-IV) of psychiatric disorders. 4th Edn. Washington : American Psychiatric Association, 1994. 45 Kissane DW, Kelly B. Demoralization, depression and desire for death: implications of the Dutch guidelines for euthanasia of the mentally ill. Aust NZ J Psychiat 2000; 34: 325–33. 46 Kissane DW, Street A, Nitschke P. Seven deaths in Darwin: case studies under the Rights of the Terminally Ill Act, Northern Territory, Australia. Lancet 1998; 352: 1097–102. 47 Brown JH, Henteleff P, Barakat S et al. Is it normal for terminally ill patients to desire death Am J Psychiat 1986; 143: 208–11. 48 Owen C, Tennant C, Levi J, Jones M. Cancer patients' attitudes to final events in life: wish for death, attitudes to cessation of treatment, suicide and euthanasia. Psycho-Oncology 1994; 3: 1–9. 49 Breitbart W, Rosenfeld BD, Passik SD. Interest in physician-assisted suicide among ambulatory HIV-infected patients. Am J Psychiat 1996; 153: 238–42. 50 Rowland LP. Assisted suicide and alternatives in amyotrophic lateral sclerosis. N Engl J Med 1998; 339: 987–9. 51 Ganzini L, Johnston WS, McFariand BH et al. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. NEngl J Med 1998; 339: 967–73. 52 Ganzini L, Lee MA, Heintz RT et al. The effect of depression treatment on elderly patients' preferences for life-sustaining medical therapy. Am J Psychiat 1994; 151: 1631–6. 53 Rosenfeld KE, Wenger NS, Phillips RH et al. Factors associated with resuscitation preference of seriously ill patients. Arch Internat Med 1996; 156: 1558–64. 54 Hooper SC, Vaughan KJ, Tennant CC et al. Major depression and refusal of life-sustaining medical treatment in the elderly. Med J Aust 1996; 165: 416–9. 55 Beck AT, Brown G, Berchick RJ et al. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiat 1990; 147: 190–5. 56 Weishaar ME, Beck AT. Hopelessness and suicide. Int Rev Psychiat 1992; 4: 177–84. 57 Henriksson MM, Isometsa ET, Hietanen PS et al. Mental disorders in cancer suicides. J Affect Dis 1995; 36: 11–20. 58 Ganzini L, Lee MA. Psychiatry and assisted suicide in the United States. N Engl J Med 1997; 336: 1824–6. 59 Zaubler TS, Sullivan MD. Psychiatry and physician-assisted suicide. Psych Clin Norm Am 1996; 19: 413–27. 60 Hendin H. Seduced by death: doctors, patients and the Dutch cure. Issues Law Med 1994; 10: 123–68. 61 Kelly BJ, Varghese FT. Assisted suicide and euthanasia: what about the clinical issues Aust NZ J Psychiat 1996; 30: 3–8. 62 Hendin H. Seduced by death. New York : Norton, 1998. 63 Kissane DW, Bloch S, Burns WI et al. Perceptions of family functioning and cancer. Psycho-Oncology 1994; 3: 259–69. 64 Kissane DW, Bloch S, McKenzie M et al. Family grief therapy: a preliminary account of a new model to promote healthy family functioning during palliative care and bereavement. Psycho-Oncology 1998; 7: 14–25. 65 Kissane DW. Models of psychological response to suffering. Prog Pall Care 1998; 6: 197–204. 66 Saunders C. The philosophy of terminal care. In: The management of terminal malignant disease. 2nd Edn. London : Edward Arnold, 1984; 333. 67 Cassell EJ. The mysterious relationship between doctor and patient. In: The nature of suffering. Oxford : Oxford University Press, 1991. 68 Byock IR. When suffering persists. J Pall Care 1994; 10: 8–13. 69 Aranda SK, Haymen-White K, Vitetta L. Home carers of the person with advanced cancer: an Australian perspective. Can Nurs 2000; (In press). 70 Payne S, Smith P, Dean S et al. Identifying the concerns of informal carers in palliative care. Pall Med 1999; 13: 37–44. 71 Grande GE, Todd CJ, Barclay SIG. Support needs in the last year of life: patient and carer dilemmas. Pall Med 1997; 11: 202–8. 72 Kristjanson LJ, Ashcroft T. The-family's cancer journey: a literature review. Can Nurs 1994; 17: 1–17. 73 Horowitz A. Family caregiving to the frail eiderly. In: P Lawton, GL Maddox (Eds.). Ann Rev Gerontol Geriat 1985; 367–75. 74 Oberst MT, Thomas SE, Gass KA, Ward SE. Caregiving demands and appraisal of stress among family caregivers. Cancer Nurs 1989; 12: 209–15. 75 Steele R, Fitch M. Needs of family caregivers of patients receiving home hospice care for cancer. One Nurs Forum 1996; 23: 823–8. 76 Jensen S, Given BA. Fatigue affecting family caregivers of cancer patients. Can Nurs 1991; 14: 181–7. 77 Laizner AM, Yost S. Needs of family caregivers of persons with cancer: a review. Semin One Nurs 1993; 9: 114–20. 78 Hinton J. Services given and help received during home care for terminal cancer. Pall Med 1996; 10: 125–34. 79 Aranda S. What is the relationship between palliative care philosophy and care received by dying clients and their primary caregiver? Melbourne : Melbourne City mission Hospice Service, 1999. 80 Aranda SK, Kelso J. The nurse as coach in care of the dying. Contemporary Nurse 1997; 6: 117–22. 81 Spencer DJ, Daniels LE. Day hospice care – a review of the literature. Pall Med 1998; 12: 219–29. 82 Kristjanson LJ. Families of palliative care patients: a model for care. In: S Aranda, M O'Connor (Eds.). Palliative care nursing: a guide to practice. Melbourne : Ausmed, 1999; 279–93. 83 Grahn G, Danielson M. Coping with the cancer experience: II. Evaluating an education and support programme for cancer patients and their significant others. Eur J Can Care 1996; 5: 182–7. 84 Ferrell BR, Rhiner M, Ferrell BA. Development and implementation of a pain education program. Cancer 1993; 72 (Suppl.): 3426–32. 85 Code K, Paul J. Supporting carers in palliative care. In: S Aranda, M O'Connor (Eds.). Palliative care nursing: a guide to practice. Melbourne : Ausmed, 1999; 295–313. 86 Harrington V, Lackey NR, Gates MF. Needs of caregivers of clinic and hospice cancer patients. Cancer Nurs 1996; 19: 118–25. 87 Axelson B, Sioden P-O. Quality of life of cancer patients and their spouses in palliative home care. Pall Med 1998; 12: 29–39. 88 Given CW, Stommel M, Given B et al. The influence of cancer patients' symptoms and functional states on patients' depression and family caregivers' reaction and depression. Health Psychol 1993; 12: 277–85. 89 Pincombe J, Tooth B. International hospice Australia. Carers of the terminally ill: an Australian study. Am J Hosp Pall Care 1996; (Jul-Aug): 44–55. 90 Given BA, Given CW, Stommel M et al. Family and out-of-pocket costs for women with breast cancer. Can Prac 1994; 2: 187–93. 91 Harrington V, Lackey NR, Gates MF et al. Needs of caregivers of clinic and hospice cancer patients. Can Nurs 1996; 19: 118–25. 92 Hileman JW, Lackey NR, Hassanein RS. Identifying the needs of home caregivers of patients with cancer. One Nurs Forum 1992; 19: 771–7. Citing Literature Volume30, Issue3June 2000Pages 377-384 ReferencesRelatedInformation

Referência(s)